Conti D, Gul P, Islam A, Martín Durán J, Pickersgill R, Draviam V. Kinetochores attached to microtubule-ends are stabilised by Astrin bound PP1 to ensure proper chromosome segregation. elife. 2019;8: pubmed publisher

Roeles J, Tsiavaliaris G. Actin-microtubule interplay coordinates spindle assembly in human oocytes. Nat Commun. 2019;10:4651 pubmed publisher

Ferro L, Can S, Turner M, Elshenawy M, Yildiz A. Kinesin and dynein use distinct mechanisms to bypass obstacles. elife. 2019;8: pubmed publisher

Obradović M, Hamelin B, Manevski N, Couto J, Sethi A, Coissieux M, et al. Glucocorticoids promote breast cancer metastasis. Nature. 2019;567:540-544 pubmed publisher

Moraes C, Witt G, Kuzikov M, Ellinger B, Calogeropoulou T, Prousis K, et al. Accelerating Drug Discovery Efforts for Trypanosomatidic Infections Using an Integrated Transnational Academic Drug Discovery Platform. SLAS Discov. 2019;24:346-361 pubmed publisher

Visetsouk M, Falat E, Garde R, Wendlick J, Gutzman J. Basal epithelial tissue folding is mediated by differential regulation of microtubules. Development. 2018;145: pubmed publisher

Bisbal M, Remedi M, Quassollo G, Caceres A, Sanchez M. Rotenone inhibits axonogenesis via an Lfc/RhoA/ROCK pathway in cultured hippocampal neurons. J Neurochem. 2018;146:570-584 pubmed publisher

Adams O, Janser F, Dislich B, Berezowska S, Humbert M, Seiler C, et al. A specific expression profile of LC3B and p62 is associated with nonresponse to neoadjuvant chemotherapy in esophageal adenocarcinomas. PLoS ONE. 2018;13:e0197610 pubmed publisher

Dhandapani R, Arokiaraj C, Taberner F, Pacifico P, Raja S, Nocchi L, et al. Control of mechanical pain hypersensitivity in mice through ligand-targeted photoablation of TrkB-positive sensory neurons. Nat Commun. 2018;9:1640 pubmed publisher

Shrestha N, Shrestha H, Ryu T, Kim H, Simkhada S, Cho Y, et al. δ-Catenin Increases the Stability of EGFR by Decreasing c-Cbl Interaction and Enhances EGFR/Erk1/2 Signaling in Prostate Cancer. Mol Cells. 2018;41:320-330 pubmed publisher

Sootichote R, Thuwajit P, Singsuksawat E, Warnnissorn M, Yenchitsomanus P, Ithimakin S, et al. Compound A attenuates toll-like receptor 4-mediated paclitaxel resistance in breast cancer and melanoma through suppression of IL-8. BMC Cancer. 2018;18:231 pubmed publisher

Jin Y, Hu W, Liu T, Rana U, Aguilera Barrantes I, Kong A, et al. Nogo-B receptor increases the resistance of estrogen receptor positive breast cancer to paclitaxel. Cancer Lett. 2018;419:233-244 pubmed publisher

Kasioulis I, Das R, Storey K. Inter-dependent apical microtubule and actin dynamics orchestrate centrosome retention and neuronal delamination. elife. 2017;6: pubmed publisher

Ritsma L, Dey Guha I, Talele N, Sole X, Salony -, Chowdhury J, et al. Integrin ?1 activation induces an anti-melanoma host response. PLoS ONE. 2017;12:e0175300 pubmed publisher

Roy R, Bassham D. TNO1, a TGN-localized SNARE-interacting protein, modulates root skewing in Arabidopsis thaliana. BMC Plant Biol. 2017;17:73 pubmed publisher

Fava L, Schüler F, Sladky V, Haschka M, Soratroi C, Eiterer L, et al. The PIDDosome activates p53 in response to supernumerary centrosomes. Genes Dev. 2017;31:34-45 pubmed publisher

Sorrentino G, Ruggeri N, Zannini A, Ingallina E, Bertolio R, Marotta C, et al. Glucocorticoid receptor signalling activates YAP in breast cancer. Nat Commun. 2017;8:14073 pubmed publisher

Rivera Serrano E, Fritch E, Scholl E, Sherry B. A Cytoplasmic RNA Virus Alters the Function of the Cell Splicing Protein SRSF2. J Virol. 2017;91: pubmed publisher

McCubbin T, Bassil E, Zhang S, Blumwald E. Vacuolar Na?/H? NHX-Type Antiporters Are Required for Cellular K? Homeostasis, Microtubule Organization and Directional Root Growth. Plants (Basel). 2014;3:409-26 pubmed publisher

Maiden S, Petrova Y, Gumbiner B. Microtubules Inhibit E-Cadherin Adhesive Activity by Maintaining Phosphorylated p120-Catenin in a Colon Carcinoma Cell Model. PLoS ONE. 2016;11:e0148574 pubmed publisher

Jayachandran P, Olmo V, Sanchez S, McFarland R, Vital E, Werner J, et al. Microtubule-associated protein 1b is required for shaping the neural tube. Neural Dev. 2016;11:1 pubmed publisher

Li W, Mukherjee A, Wu J, Zhang L, Teves M, Li H, et al. Sperm Associated Antigen 6 (SPAG6) Regulates Fibroblast Cell Growth, Morphology, Migration and Ciliogenesis. Sci Rep. 2015;5:16506 pubmed publisher

Suzuki R, Hotta K, Oka K. Spatiotemporal quantification of subcellular ATP levels in a single HeLa cell during changes in morphology. Sci Rep. 2015;5:16874 pubmed publisher

Wang J, Jiang Z, Lam W, Gullen E, Yu Z, Wei Y, et al. Study of Malformin C, a Fungal Source Cyclic Pentapeptide, as an Anti-Cancer Drug. PLoS ONE. 2015;10:e0140069 pubmed publisher

Peiris Pagès M, Smith D, Gyorffy B, Sotgia F, Lisanti M. Proteomic identification of prognostic tumour biomarkers, using chemotherapy-induced cancer-associated fibroblasts. Aging (Albany NY). 2015;7:816-38 pubmed

Taccioli C, Sorrentino G, Zannini A, Caroli J, Beneventano D, Anderlucci L, et al. MDP, a database linking drug response data to genomic information, identifies dasatinib and statins as a combinatorial strategy to inhibit YAP/TAZ in cancer cells. Oncotarget. 2015;6:38854-65 pubmed publisher

Marchesin V, Castro Castro A, Lodillinsky C, Castagnino A, Cyrta J, Bonsang Kitzis H, et al. ARF6-JIP3/4 regulate endosomal tubules for MT1-MMP exocytosis in cancer invasion. J Cell Biol. 2015;211:339-58 pubmed publisher

Yu J, Liu Y, Zhang L, Zhao J, Ren J, Zhang L, et al. Self-aggregated nanoparticles of linoleic acid-modified glycol chitosan conjugate as delivery vehicles for paclitaxel: preparation, characterization and evaluation. J Biomater Sci Polym Ed. 2015;26:1475-89 pubmed publisher

Somjaipeng S, Medina A, Kwaśna H, Ordaz Ortiz J, Magan N. Isolation, identification, and ecology of growth and taxol production by an endophytic strain of Paraconiothyrium variabile from English yew trees (Taxus baccata). Fungal Biol. 2015;119:1022-1031 pubmed publisher

Han F, Zhang L, Zhou Y, Yi X. Caveolin-1 regulates cell apoptosis and invasion ability in paclitaxel-induced multidrug-resistant A549 lung cancer cells. Int J Clin Exp Pathol. 2015;8:8937-47 pubmed

Froidevaux Klipfel L, Targa B, Cantaloube I, Ahmed Zaïd H, Poüs C, Baillet A. Septin cooperation with tubulin polyglutamylation contributes to cancer cell adaptation to taxanes. Oncotarget. 2015;6:36063-80 pubmed publisher

Guan D, Chen H, Liao S, Zhao T. Combination of temozolomide and Taxol exerts a synergistic inhibitory effect on Taxol?resistant glioma cells via inhibition of glucose metabolism. Mol Med Rep. 2015;12:7705-11 pubmed publisher

Makvandi M, Tilahun E, Lieberman B, Anderson R, Zeng C, Xu K, et al. The sigma-2 receptor as a therapeutic target for drug delivery in triple negative breast cancer. Biochem Biophys Res Commun. 2015;467:1070-5 pubmed publisher

He X, Liu Z, He Q, Qin J, Liu N, Zhang L, et al. Identification of novel microtubule-binding proteins by taxol-mediated microtubule stabilization and mass spectrometry analysis. Thorac Cancer. 2015;6:649-54 pubmed publisher

Coles G, Baglia L, Ackerman K. KIF7 Controls the Proliferation of Cells of the Respiratory Airway through Distinct Microtubule Dependent Mechanisms. PLoS Genet. 2015;11:e1005525 pubmed publisher

Derbyshire P, Ménard D, Green P, Saalbach G, Buschmann H, Lloyd C, et al. Proteomic Analysis of Microtubule Interacting Proteins over the Course of Xylem Tracheary Element Formation in Arabidopsis. Plant Cell. 2015;27:2709-26 pubmed publisher

de Lange J, Faramarz A, Oostra A, de Menezes R, van der Meulen I, Rooimans M, et al. Defective sister chromatid cohesion is synthetically lethal with impaired APC/C function. Nat Commun. 2015;6:8399 pubmed publisher

Wu L, Guo L, Liang Y, Liu X, Jiang L, Wang L. Curcumin suppresses stem-like traits of lung cancer cells via inhibiting the JAK2/STAT3 signaling pathway. Oncol Rep. 2015;34:3311-7 pubmed publisher

Single A, Beetham H, Telford B, Guilford P, Chen A. A Comparison of Real-Time and Endpoint Cell Viability Assays for Improved Synthetic Lethal Drug Validation. J Biomol Screen. 2015;20:1286-93 pubmed publisher

Jonsson E, Yamada M, Vale R, Goshima G. Clustering of a kinesin-14 motor enables processive retrograde microtubule-based transport in plants. Nat Plants. 2015;1: pubmed

Kempin W, Kaule S, Reske T, Grabow N, Petersen S, Nagel S, et al. In vitro evaluation of paclitaxel coatings for delivery via drug-coated balloons. Eur J Pharm Biopharm. 2015;96:322-8 pubmed publisher

Pan B, Wang Y, Lai M, Mu Y, Huang B. Cordycepin induced MA-10 mouse Leydig tumor cell apoptosis by regulating p38 MAPKs and PI3K/AKT signaling pathways. Sci Rep. 2015;5:13372 pubmed publisher

Liu Z, Li X, Li W, Yang Y, Tao Y, Yao Y. Robotic nerve-sparing radical hysterectomy for locally advanced cervical cancer after neoadjuvant chemotherapy. Int J Gynaecol Obstet. 2015;131:152-5 pubmed publisher

Liu P, Gan W, Chin Y, Ogura K, Guo J, Zhang J, et al. PtdIns(3,4,5)P3-Dependent Activation of the mTORC2 Kinase Complex. Cancer Discov. 2015;5:1194-209 pubmed publisher

DeBonis S, Neumann E, Skoufias D. Self protein-protein interactions are involved in TPPP/p25 mediated microtubule bundling. Sci Rep. 2015;5:13242 pubmed publisher

Liu W, Zhong Z, Cao L, Li H, Zhang T, Lin W. Paclitaxel-induced lung injury and its amelioration by parecoxib sodium. Sci Rep. 2015;5:12977 pubmed publisher

Sun H, Liu X, Liu Q, Wang F, Bao X, Zhang D. Reversal of P-glycoprotein-mediated multidrug resistance by the novel tetrandrine derivative W6. J Asian Nat Prod Res. 2015;17:638-48 pubmed publisher

Lu H, Samanta D, Xiang L, Zhang H, Hu H, Chen I, et al. Chemotherapy triggers HIF-1-dependent glutathione synthesis and copper chelation that induces the breast cancer stem cell phenotype. Proc Natl Acad Sci U S A. 2015;112:E4600-9 pubmed publisher

Ying L, Chunxia Y, Wei L. Inhibition of ovarian cancer cell growth by a novel TAK1 inhibitor LYTAK1. Cancer Chemother Pharmacol. 2015;76:641-50 pubmed publisher

Ma B, Yu J, Xie C, Sun L, Lin S, Ding J, et al. Toll-Like Receptors Promote Mitochondrial Translocation of Nuclear Transcription Factor Nuclear Factor of Activated T-Cells in Prolonged Microglial Activation. J Neurosci. 2015;35:10799-814 pubmed publisher

Wang B, Lee C, Witt A, Thakkar A, Ince T. Heat shock factor 1 induces cancer stem cell phenotype in breast cancer cell lines. Breast Cancer Res Treat. 2015;153:57-66 pubmed publisher

Feng X, Gao X, Kang T, Jiang D, Yao J, Jing Y, et al. Mammary-Derived Growth Inhibitor Targeting Peptide-Modified PEG-PLA Nanoparticles for Enhanced Targeted Glioblastoma Therapy. Bioconjug Chem. 2015;26:1850-61 pubmed publisher

Oyama K, Arai T, Isaka A, Sekiguchi T, Itoh H, Seto Y, et al. Directional bleb formation in spherical cells under temperature gradient. Biophys J. 2015;109:355-64 pubmed publisher

Konstantakou E, Voutsinas G, Velentzas A, Basogianni A, Paronis E, Balafas E, et al. 3-BrPA eliminates human bladder cancer cells with highly oncogenic signatures via engagement of specific death programs and perturbation of multiple signaling and metabolic determinants. Mol Cancer. 2015;14:135 pubmed publisher

De S, Zhou H, DeSantis D, Croniger C, Li X, Stark G. Erlotinib protects against LPS-induced endotoxicity because TLR4 needs EGFR to signal. Proc Natl Acad Sci U S A. 2015;112:9680-5 pubmed publisher

Yan K, Li L, Wang X, Hong R, Zhang Y, Yang H, et al. The deubiquitinating enzyme complex BRISC is required for proper mitotic spindle assembly in mammalian cells. J Cell Biol. 2015;210:209-24 pubmed publisher

Li Villarreal N, Forbes M, Loza A, Chen J, Ma T, Helde K, et al. Dachsous1b cadherin regulates actin and microtubule cytoskeleton during early zebrafish embryogenesis. Development. 2015;142:2704-18 pubmed publisher

Pérez E, Martínez A, Teijón C, Olmo R, Teijón J, Blanco M. Improved antitumor effect of paclitaxel administered in vivo as pH and glutathione-sensitive nanohydrogels. Int J Pharm. 2015;492:10-9 pubmed publisher

Lange J, Steinwachs J, Kolb T, Lautscham L, Harder I, Whyte G, et al. Microconstriction arrays for high-throughput quantitative measurements of cell mechanical properties. Biophys J. 2015;109:26-34 pubmed publisher

Lim J, Lee K, Woo H, Kang D, Rhee S. Control of the pericentrosomal H2O2 level by peroxiredoxin I is critical for mitotic progression. J Cell Biol. 2015;210:23-33 pubmed publisher

Mo L, Pospichalova V, Huang Z, Murphy S, Payne S, Wang F, et al. Ascites Increases Expression/Function of Multidrug Resistance Proteins in Ovarian Cancer Cells. PLoS ONE. 2015;10:e0131579 pubmed publisher

Lindenblatt D, Fischer E, Cohrs S, Schibli R, Grünberg J. Paclitaxel improved anti-L1CAM lutetium-177 radioimmunotherapy in an ovarian cancer xenograft model. EJNMMI Res. 2014;4:54 pubmed publisher

Zhou J, Li G, Zheng Y, Shen H, Hu X, Ming Q, et al. A novel autophagy/mitophagy inhibitor liensinine sensitizes breast cancer cells to chemotherapy through DNM1L-mediated mitochondrial fission. Autophagy. 2015;11:1259-79 pubmed publisher

Astanina K, Koch M, Jüngst C, Zumbusch A, Kiemer A. Lipid droplets as a novel cargo of tunnelling nanotubes in endothelial cells. Sci Rep. 2015;5:11453 pubmed publisher

Kohoutová L, Kourová H, Nagy S, Volc J, Halada P, Mészáros T, et al. The Arabidopsis mitogen-activated protein kinase 6 is associated with γ-tubulin on microtubules, phosphorylates EB1c and maintains spindle orientation under nitrosative stress. New Phytol. 2015;207:1061-74 pubmed publisher

Zhang H, Jing X, Wu X, Hu J, Zhang X, Wang X, et al. Suppression of multidrug resistance by rosiglitazone treatment in human ovarian cancer cells through downregulation of FZD1 and MDR1 genes. Anticancer Drugs. 2015;26:706-15 pubmed publisher

Koutras A, Kalogeras K, Wirtz R, Alexopoulou Z, Bobos M, Zagouri F, et al. Evaluation of the prognostic significance of HER family mRNA expression in high-risk early breast cancer: a Hellenic Cooperative Oncology Group (HeCOG) validation study. J Transl Med. 2015;13:171 pubmed publisher

Fuse S, Ikebe A, Oosumi K, Karasawa T, Matsumura K, Izumikawa M, et al. Asymmetric Total Synthesis of ent-Pyripyropene A. Chemistry. 2015;21:9454-60 pubmed publisher

Vasudevan S, Thomas S, Sivakumar K, Komalam R, Sreerekha K, Rajasekharan K, et al. Diaminothiazoles evade multidrug resistance in cancer cells and xenograft tumour models and develop transient specific resistance: understanding the basis of broad-spectrum versus specific resistance. Carcinogenesis. 2015;36:883-93 pubmed publisher

Maki T, Grimaldi A, Fuchigami S, Kaverina I, Hayashi I. CLASP2 Has Two Distinct TOG Domains That Contribute Differently to Microtubule Dynamics. J Mol Biol. 2015;427:2379-95 pubmed publisher

Chakraborty S, Tai D, Lin Y, Chiou T. Antitumor and antimicrobial activity of some cyclic tetrapeptides and tripeptides derived from marine bacteria. Mar Drugs. 2015;13:3029-45 pubmed publisher

Takano M, Kakizoe S, Kawami M, Nagai J, Patanasethnont D, Sripanidkulchai B, et al. Modulation of P-glycoprotein function and multidrug resistance in cancer cells by Thai plant extracts. Pharmazie. 2014;69:823-8 pubmed

Prosser S, Sahota N, Pelletier L, Morrison C, Fry A. Nek5 promotes centrosome integrity in interphase and loss of centrosome cohesion in mitosis. J Cell Biol. 2015;209:339-48 pubmed publisher

Ashraf S, Beech R, Hancock M, Prichard R. Ivermectin binds to Haemonchus contortus tubulins and promotes stability of microtubules. Int J Parasitol. 2015;45:647-54 pubmed publisher

Tian R, Wang H, Niu R, Ding D. Drug delivery with nanospherical supramolecular cell penetrating peptide-taxol conjugates containing a high drug loading. J Colloid Interface Sci. 2015;453:15-20 pubmed publisher

Ren J, Huang H, Liu Y, Zheng X, Zou Q. An Atomic Force Microscope Study Revealed Two Mechanisms in the Effect of Anticancer Drugs on Rate-Dependent Young's Modulus of Human Prostate Cancer Cells. PLoS ONE. 2015;10:e0126107 pubmed publisher

Armond J, Vladimirou E, Erent M, McAinsh A, Burroughs N. Probing microtubule polymerisation state at single kinetochores during metaphase chromosome motion. J Cell Sci. 2015;128:1991-2001 pubmed publisher

Hu Y, Xu K, Yagüe E. miR-218 targets survivin and regulates resistance to chemotherapeutics in breast cancer. Breast Cancer Res Treat. 2015;151:269-80 pubmed publisher

Yu J, Qiu H, Liu X, Wang M, Gao Y, Chory J, et al. Characterization of tub4(P287L) , a β-tubulin mutant, revealed new aspects of microtubule regulation in shade. J Integr Plant Biol. 2015;57:757-69 pubmed publisher

Karamysheva Z, Diaz Martinez L, Warrington R, Yu H. Graded requirement for the spliceosome in cell cycle progression. Cell Cycle. 2015;14:1873-83 pubmed publisher

Yang F, Chen Y, Dai W. Sumoylation of Kif18A plays a role in regulating mitotic progression. BMC Cancer. 2015;15:197 pubmed publisher

Turi Z, Hocsak E, Racz B, Szabo A, Balogh A, Sumegi B, et al. Role of mitochondrial network stabilisation by a human small heat shock protein in tumour malignancy. J Cancer. 2015;6:470-6 pubmed publisher

Rizopoulos Z, Balistreri G, Kilcher S, Martin C, Syedbasha M, Helenius A, et al. Vaccinia Virus Infection Requires Maturation of Macropinosomes. Traffic. 2015;16:814-31 pubmed publisher

Bekier M, Mazur T, Rashid M, Taylor W. Borealin dimerization mediates optimal CPC checkpoint function by enhancing localization to centromeres and kinetochores. Nat Commun. 2015;6:6775 pubmed publisher

Liu Z, Luo Q, Guo C. Bim and VDAC1 are hierarchically essential for mitochondrial ATF2 mediated cell death. Cancer Cell Int. 2015;15:34 pubmed publisher

Zou D, Wang D, Li R, Tang Y, Yuan L, Long X, et al. MiR-197 induces Taxol resistance in human ovarian cancer cells by regulating NLK. Tumour Biol. 2015;36:6725-32 pubmed publisher

Ren Y, Zhou X, Yang J, Liu X, Zhao X, Wang Q, et al. AC1MMYR2 impairs high dose paclitaxel-induced tumor metastasis by targeting miR-21/CDK5 axis. Cancer Lett. 2015;362:174-82 pubmed publisher

Arulanandam R, Batenchuk C, Varette O, Zakaria C, Garcia V, Forbes N, et al. Microtubule disruption synergizes with oncolytic virotherapy by inhibiting interferon translation and potentiating bystander killing. Nat Commun. 2015;6:6410 pubmed publisher

Lee C. Overexpression of Tyro3 receptor tyrosine kinase leads to the acquisition of taxol resistance in ovarian cancer cells. Mol Med Rep. 2015;12:1485-92 pubmed publisher

Hou Z, Luo X, Zhang W, Peng F, Cui B, Wu S, et al. Flubendazole, FDA-approved anthelmintic, targets breast cancer stem-like cells. Oncotarget. 2015;6:6326-40 pubmed

Li Y, Wu Z, He W, Qin C, Yao J, Zhou J, et al. Globular protein-coated Paclitaxel nanosuspensions: interaction mechanism, direct cytosolic delivery, and significant improvement in pharmacokinetics. Mol Pharm. 2015;12:1485-500 pubmed publisher

Lovitt C, Shelper T, Avery V. Evaluation of chemotherapeutics in a three-dimensional breast cancer model. J Cancer Res Clin Oncol. 2015;141:951-9 pubmed publisher

Chen Y, Wang H, Ho C, Chen H, Li S, Chan H, et al. 5-demethylnobiletin promotes the formation of polymerized tubulin, leads to G2/M phase arrest and induces autophagy via JNK activation in human lung cancer cells. J Nutr Biochem. 2015;26:484-504 pubmed publisher

Debeb B, Smith D, Li L, Larson R, Xu W, Woodward W. Differential effect of phosphorylation-defective survivin on radiation response in estrogen receptor-positive and -negative breast cancer. PLoS ONE. 2015;10:e0120719 pubmed publisher

Pan T, Hsu S, Wang P, Cheng Y, Chang Y, Saha S, et al. FLJ25439, a novel cytokinesis-associated protein, induces tetraploidization and maintains chromosomal stability via enhancing expression of endoplasmic reticulum stress chaperones. Cell Cycle. 2015;14:1174-87 pubmed publisher

Li L, Hu J, He T, Zhang Q, Yang X, Lan X, et al. P38/MAPK contributes to endothelial barrier dysfunction via MAP4 phosphorylation-dependent microtubule disassembly in inflammation-induced acute lung injury. Sci Rep. 2015;5:8895 pubmed publisher

Chen C, Cao F, Bai L, Liu Y, Xie J, Wang W, et al. IKKβ Enforces a LIN28B/TCF7L2 Positive Feedback Loop That Promotes Cancer Cell Stemness and Metastasis. Cancer Res. 2015;75:1725-35 pubmed publisher

Visconti R, Della Monica R, Palazzo L, D Alessio F, Raia M, Improta S, et al. The Fcp1-Wee1-Cdk1 axis affects spindle assembly checkpoint robustness and sensitivity to antimicrotubule cancer drugs. Cell Death Differ. 2015;22:1551-60 pubmed publisher

Matsuhashi T, Shimizu M, Negishi Y, Takeshita T, Takahashi H. A low, non-toxic dose of paclitaxel can prevent dendritic cell-precursors from becoming tolerogenic dendritic cells with impaired functions. Biomed Res. 2014;35:369-80 pubmed publisher

Yamada H, Zhang Y, Reddy A, Mohammed A, Lightfoot S, Dai W, et al. Tumor-promoting/progressing role of additional chromosome instability in hepatic carcinogenesis in Sgo1 (Shugoshin 1) haploinsufficient mice. Carcinogenesis. 2015;36:429-40 pubmed publisher

Alam Escamilla D, Estrada Muñiz E, Solís Villegas E, Elizondo G, Vega L. Genotoxic and cytostatic effects of 6-pentadecyl salicylic anacardic acid in transformed cell lines and peripheral blood mononuclear cells. Mutat Res Genet Toxicol Environ Mutagen. 2015;777:43-53 pubmed publisher

He W, Lv Y, Zhao Y, Xu C, Jin Z, Qin C, et al. Core-shell structured gel-nanocarriers for sustained drug release and enhanced antitumor effect. Int J Pharm. 2015;484:163-71 pubmed publisher

Masuda K, Chiyoda T, Sugiyama N, Segura Cabrera A, Kabe Y, Ueki A, et al. LATS1 and LATS2 phosphorylate CDC26 to modulate assembly of the tetratricopeptide repeat subcomplex of APC/C. PLoS ONE. 2015;10:e0118662 pubmed publisher

Naganuma T, Latib A, Sgueglia G, Menozzi A, Castriota F, Micari A, et al. A 2-year follow-up of a randomized multicenter study comparing a paclitaxel drug-eluting balloon with a paclitaxel-eluting stent in small coronary vessels the BELLO study. Int J Cardiol. 2015;184:17-21 pubmed publisher

Carraz M, Lavergne C, Jullian V, Wright M, Gairin J, Gonzales de la Cruz M, et al. Antiproliferative activity and phenotypic modification induced by selected Peruvian medicinal plants on human hepatocellular carcinoma Hep3B cells. J Ethnopharmacol. 2015;166:185-99 pubmed publisher

Kim J, Kim Y, Bae K, Park T, Lee J, Park K. Tumor-targeted delivery of paclitaxel using low density lipoprotein-mimetic solid lipid nanoparticles. Mol Pharm. 2015;12:1230-41 pubmed publisher

Mäki Jouppila J, Pruikkonen S, Tambe M, Aure M, Halonen T, Salmela A, et al. MicroRNA let-7b regulates genomic balance by targeting Aurora B kinase. Mol Oncol. 2015;9:1056-70 pubmed publisher

Huang P, Chen C, Hsu I, Salim S, Kao S, Cheng C, et al. Huntingtin-associated protein 1 interacts with breakpoint cluster region protein to regulate neuronal differentiation. PLoS ONE. 2015;10:e0116372 pubmed publisher

Nicholas M, Höök P, Brenner S, Wynne C, Vallee R, Gennerich A. Control of cytoplasmic dynein force production and processivity by its C-terminal domain. Nat Commun. 2015;6:6206 pubmed publisher

Zhu S, Zhang Y, Sheng X, Xu M, Wu S, Shen Y, et al. Deacetyl-mycoepoxydiene, isolated from plant endophytic fungi Phomosis sp. demonstrates anti-microtubule activity in MCF-7 cells. Biomed Pharmacother. 2015;69:82-9 pubmed publisher

Zhu C, Ganguly A, Baskin T, McClosky D, Anderson C, Foster C, et al. The fragile Fiber1 kinesin contributes to cortical microtubule-mediated trafficking of cell wall components. Plant Physiol. 2015;167:780-92 pubmed publisher

Liu Z, Zhu G, Getzenberg R, Veltri R. The Upregulation of PI3K/Akt and MAP Kinase Pathways is Associated with Resistance of Microtubule-Targeting Drugs in Prostate Cancer. J Cell Biochem. 2015;116:1341-9 pubmed publisher

Goldstein D, El Maraghi R, Hammel P, Heinemann V, Kunzmann V, Sastre J, et al. nab-Paclitaxel plus gemcitabine for metastatic pancreatic cancer: long-term survival from a phase III trial. J Natl Cancer Inst. 2015;107: pubmed publisher

Fu A, Yu Z, Song Y, Zhang E. Silencing of glutaminase 1 resensitizes Taxol-resistant breast cancer cells to Taxol. Mol Med Rep. 2015;11:4727-33 pubmed publisher

Spitler L, Boasberg P, O Day S, Hamid O, Cruickshank S, Mesko S, et al. Phase II study of nab-paclitaxel and bevacizumab as first-line therapy for patients with unresectable stage III and IV melanoma. Am J Clin Oncol. 2015;38:61-7 pubmed publisher

Spigel D, Patel J, Reynolds C, Garon E, Hermann R, Govindan R, et al. Quality of life analyses from the randomized, open-label, phase III PointBreak study of pemetrexed-carboplatin-bevacizumab followed by maintenance pemetrexed-bevacizumab versus paclitaxel-carboplatin-bevacizumab followed by maintenance bevacizumab in. J Thorac Oncol. 2015;10:353-9 pubmed publisher

Calleja P, Espuelas S, Vauthier C, Ponchel G, Irache J. Controlled Release, Intestinal Transport, and Oral Bioavailablity of Paclitaxel Can be Considerably Increased Using Suitably Tailored Pegylated Poly(Anhydride) Nanoparticles. J Pharm Sci. 2015;104:2877-86 pubmed publisher

Kondo R, Watanabe S, Ishikawa D, Tanaka T, Ohshima Y, Asakawa K, et al. [A case of thymic cancer effectively treated by weekly paclitaxel combined with carboplatin]. Gan To Kagaku Ryoho. 2014;41:2607-9 pubmed

Stolz A, Ertych N, Bastians H. A phenotypic screen identifies microtubule plus end assembly regulators that can function in mitotic spindle orientation. Cell Cycle. 2015;14:827-37 pubmed publisher

Uchimura S, Fujii T, Takazaki H, Ayukawa R, Nishikawa Y, Minoura I, et al. A flipped ion pair at the dynein-microtubule interface is critical for dynein motility and ATPase activation. J Cell Biol. 2015;208:211-22 pubmed publisher

Bucak A, Ozdemir C, Ulu S, Gonul Y, Aycicek A, Uysal M, et al. Investigation of protective role of curcumin against paclitaxel-induced inner ear damage in rats. Laryngoscope. 2015;125:1175-82 pubmed publisher

Maletzki C, Gock M, Randow M, Klar E, Huehns M, Prall F, et al. Establishment and characterization of cell lines from chromosomal instable colorectal cancer. World J Gastroenterol. 2015;21:164-76 pubmed publisher

Isozaki N, Ando S, Nakahara T, Shintaku H, Kotera H, Meyhofer E, et al. Control of microtubule trajectory within an electric field by altering surface charge density. Sci Rep. 2015;5:7669 pubmed publisher

Barry W, Dang C, Yardley D, Moy B, Marcom P, Albain K, et al. Adjuvant paclitaxel and trastuzumab for node-negative, HER2-positive breast cancer. N Engl J Med. 2015;372:134-41 pubmed publisher

Yu C, Liu S, Hsu J, Hsu J, Kudryavtsev K, Guh J. KUD773, a phenylthiazole derivative, displays anticancer activity in human hormone-refractory prostate cancers through inhibition of tubulin polymerization and anti-Aurora A activity. J Biomed Sci. 2015;22:2 pubmed publisher

Atanaskova Mesinkovska N, Conic R, Kiracofe E, Vidimos A. Treatment of invasive squamous cell carcinomas in an open Clagett window. Dermatol Surg. 2015;41:170-2 pubmed publisher

Toyokawa T, Tanaka H, Muguruma K, Tamura T, Sakurai K, Kubo N, et al. Primary gastric small cell carcinoma: a series of seven cases. Anticancer Res. 2015;35:563-7 pubmed

Otake A, Yoshino K, Ueda Y, Sawada K, Mabuchi S, Kimura T, et al. Usefulness of duloxetine for Paclitaxel-induced peripheral neuropathy treatment in gynecological cancer patients. Anticancer Res. 2015;35:359-63 pubmed

Dilling T. Radiation dose in non-small cell lung cancer: too much of a good thing?. Int J Radiat Oncol Biol Phys. 2014;90:979-82 pubmed publisher

Shulman L, Berry D, Cirrincione C, Hudis C, Winer E. Reply to V. Amoroso et al. J Clin Oncol. 2015;33:291 pubmed publisher

Amoroso V, Pedersini R, Sharratt P, Vassalli L, Ferrari L, Sigala S, et al. Should adjuvant weekly paclitaxel be considered less efficacious than anthracyclines plus cyclophosphamide for lower-risk patients with early-stage breast cancer?. J Clin Oncol. 2015;33:290 pubmed publisher

Kendra K, Plummer R, Salgia R, O Brien M, Paul E, Suttle A, et al. A multicenter phase I study of pazopanib in combination with paclitaxel in first-line treatment of patients with advanced solid tumors. Mol Cancer Ther. 2015;14:461-9 pubmed publisher

Carey S, Rahman A, Kraning Rush C, Romero B, Somasegar S, Torre O, et al. Comparative mechanisms of cancer cell migration through 3D matrix and physiological microtracks. Am J Physiol Cell Physiol. 2015;308:C436-47 pubmed publisher

Busschots S, O Toole S, O Leary J, Stordal B. Carboplatin and taxol resistance develops more rapidly in functional BRCA1 compared to dysfunctional BRCA1 ovarian cancer cells. Exp Cell Res. 2015;336:1-14 pubmed publisher

Akiyama K, Maishi N, Ohga N, Hida Y, Ohba Y, Alam M, et al. Inhibition of multidrug transporter in tumor endothelial cells enhances antiangiogenic effects of low-dose metronomic paclitaxel. Am J Pathol. 2015;185:572-80 pubmed publisher

Choi W, Kim H, Xia Z. JNK inhibition of VMAT2 contributes to rotenone-induced oxidative stress and dopamine neuron death. Toxicology. 2015;328:75-81 pubmed publisher

Srivastava K, Hu J, Korn C, Savant S, Teichert M, Kapel S, et al. Postsurgical adjuvant tumor therapy by combining anti-angiopoietin-2 and metronomic chemotherapy limits metastatic growth. Cancer Cell. 2014;26:880-895 pubmed publisher

Connolly R, Leal J, Goetz M, Zhang Z, Zhou X, Jacobs L, et al. TBCRC 008: early change in 18F-FDG uptake on PET predicts response to preoperative systemic therapy in human epidermal growth factor receptor 2-negative primary operable breast cancer. J Nucl Med. 2015;56:31-7 pubmed publisher

Ansaloni L, Coccolini F, Morosi L, Ballerini A, Ceresoli M, Grosso G, et al. Pharmacokinetics of concomitant cisplatin and paclitaxel administered by hyperthermic intraperitoneal chemotherapy to patients with peritoneal carcinomatosis from epithelial ovarian cancer. Br J Cancer. 2015;112:306-12 pubmed publisher

Sun N, Huang S, Chang P, Lu H, Chao C. Transcriptomic profiling of taxol-resistant ovarian cancer cells identifies FKBP5 and the androgen receptor as critical markers of chemotherapeutic response. Oncotarget. 2014;5:11939-56 pubmed

Lam S, de Groot S, Honkoop A, Jager A, ten Tije A, Bos M, et al. Paclitaxel and bevacizumab with or without capecitabine as first-line treatment for HER2-negative locally recurrent or metastatic breast cancer: a multicentre, open-label, randomised phase 2 trial. Eur J Cancer. 2014;50:3077-88 pubmed

Fizazi K, Pagliaro L, Laplanche A, Fléchon A, Mardiak J, Geoffrois L, et al. Personalised chemotherapy based on tumour marker decline in poor prognosis germ-cell tumours (GETUG 13): a phase 3, multicentre, randomised trial. Lancet Oncol. 2014;15:1442-50 pubmed publisher

Azzarito T, Venturi G, Cesolini A, Fais S. Lansoprazole induces sensitivity to suboptimal doses of paclitaxel in human melanoma. Cancer Lett. 2015;356:697-703 pubmed publisher

Rithirangsriroj K, Manchana T, Akkayagorn L. Efficacy of acupuncture in prevention of delayed chemotherapy induced nausea and vomiting in gynecologic cancer patients. Gynecol Oncol. 2015;136:82-6 pubmed publisher

Bonneau C, Rouzier R, Geyl C, Cortez A, Castela M, Lis R, et al. Predictive markers of chemoresistance in advanced stages epithelial ovarian carcinoma. Gynecol Oncol. 2015;136:112-20 pubmed publisher

Phippen N, Leath C, Havrilesky L, Barnett J. Bevacizumab in recurrent, persistent, or advanced stage carcinoma of the cervix: is it cost-effective?. Gynecol Oncol. 2015;136:43-7 pubmed publisher

Liourdi D, Kallidonis P, Kyriazis I, Tsamandas A, Karnabatidis D, Kitrou P, et al. Evaluation of the distribution of Paclitaxel by immunohistochemistry and nuclear magnetic resonance spectroscopy after the application of a drug-eluting balloon in the porcine ureter. J Endourol. 2015;29:580-9 pubmed publisher

Roberts K, Manicassamy B, Lamb R. Influenza A virus uses intercellular connections to spread to neighboring cells. J Virol. 2015;89:1537-49 pubmed publisher

Jones L, Villemant C, Starborg T, Salter A, Goddard G, Ruane P, et al. Dynein light intermediate chains maintain spindle bipolarity by functioning in centriole cohesion. J Cell Biol. 2014;207:499-516 pubmed publisher

Teijaro C, Munagala S, Zhao S, Sirasani G, Kokkonda P, Malofeeva E, et al. Synthesis and biological evaluation of pentacyclic strychnos alkaloids as selective modulators of the ABCC10 (MRP7) efflux pump. J Med Chem. 2014;57:10383-90 pubmed publisher

Bender M, Thon J, Ehrlicher A, Wu S, Mazutis L, Deschmann E, et al. Microtubule sliding drives proplatelet elongation and is dependent on cytoplasmic dynein. Blood. 2015;125:860-8 pubmed publisher

Chang C, Lee C, Su M, Tsai C, Chen M. BGLF4 kinase modulates the structure and transport preference of the nuclear pore complex to facilitate nuclear import of Epstein-Barr virus lytic proteins. J Virol. 2015;89:1703-18 pubmed publisher

Mauri L, Kereiakes D, Yeh R, Driscoll Shempp P, Cutlip D, Steg P, et al. Twelve or 30 months of dual antiplatelet therapy after drug-eluting stents. N Engl J Med. 2014;371:2155-66 pubmed publisher

Montagner I, Merlo A, Zuccolotto G, Renier D, Campisi M, Pasut G, et al. Peritoneal tumor carcinomatosis: pharmacological targeting with hyaluronan-based bioconjugates overcomes therapeutic indications of current drugs. PLoS ONE. 2014;9:e112240 pubmed publisher

Huang S, Ren Y, Wang P, Li Y, Wang X, Zhuang H, et al. Transcription factor CREB is involved in CaSR-mediated cytoskeleton gene expression. Anat Rec (Hoboken). 2015;298:501-12 pubmed publisher

Lin X, Liao Y, Xie J, Liu S, Su L, Zou H. Op18/stathmin is involved in the resistance of taxol among different epithelial carcinoma cell lines. Cancer Biother Radiopharm. 2014;29:376-86 pubmed publisher

Zheng N, Dai W, Zhang H, Wang X, Wang J, Zhang X, et al. Lanreotide-conjugated PEG-DSPE micelles: an efficient nanocarrier targeting to somatostatin receptor positive tumors. J Drug Target. 2015;23:67-78 pubmed publisher

Choi B, Chattopadhaya S, Thanh L, Feng L, Nguyen Q, Lim C, et al. Suprafenacine, an indazole-hydrazide agent, targets cancer cells through microtubule destabilization. PLoS ONE. 2014;9:e110955 pubmed publisher

Cheng Y, Lee Y, Chiu W, Tsai J, Su Y, Hung A, et al. High Id1 expression, a generally negative prognostic factor, paradoxically predicts a favorable prognosis for adjuvant paclitaxel plus cisplatin therapy in surgically treated lung cancer patients. Oncotarget. 2014;5:11564-75 pubmed

Li W, Wan L, Zhai L, Wang J. Effects of SC-560 in combination with cisplatin or taxol on angiogenesis in human ovarian cancer xenografts. Int J Mol Sci. 2014;15:19265-80 pubmed publisher

Lee M, López Díaz F, Khan S, Tariq M, Dayn Y, Vaske C, et al. Single-cell analyses of transcriptional heterogeneity during drug tolerance transition in cancer cells by RNA sequencing. Proc Natl Acad Sci U S A. 2014;111:E4726-35 pubmed publisher

Mihailovska E, Raith M, Valencia R, Fischer I, Al Banchaabouchi M, Herbst R, et al. Neuromuscular synapse integrity requires linkage of acetylcholine receptors to postsynaptic intermediate filament networks via rapsyn-plectin 1f complexes. Mol Biol Cell. 2014;25:4130-49 pubmed publisher

Heaslip A, Nelson S, Lombardo A, Beck Previs S, Armstrong J, Warshaw D. Cytoskeletal dependence of insulin granule movement dynamics in INS-1 beta-cells in response to glucose. PLoS ONE. 2014;9:e109082 pubmed publisher

Zhang L, Wu C, Zhang Y, Liu F, Wang X, Zhao M, et al. Comparison of efficacy and toxicity of traditional Chinese medicine (TCM) herbal mixture LQ and conventional chemotherapy on lung cancer metastasis and survival in mouse models. PLoS ONE. 2014;9:e109814 pubmed publisher

Lee C, Lord S, Grunewald T, Gebski V, Hardy Bessard A, Sehouli J, et al. Impact of secondary cytoreductive surgery on survival in patients with platinum sensitive recurrent ovarian cancer: analysis of the CALYPSO trial. Gynecol Oncol. 2015;136:18-24 pubmed publisher

Sprouse A, Herbert B. Resveratrol augments paclitaxel treatment in MDA-MB-231 and paclitaxel-resistant MDA-MB-231 breast cancer cells. Anticancer Res. 2014;34:5363-74 pubmed

Liu X, Zhou Y, Liu X, Peng A, Gong H, Huang L, et al. MPHOSPH1: a potential therapeutic target for hepatocellular carcinoma. Cancer Res. 2014;74:6623-34 pubmed publisher

Shirakawa T, Kato K, Nagashima K, Nishikawa A, Sawada R, Takahashi N, et al. A retrospective study of docetaxel or paclitaxel in patients with advanced or recurrent esophageal squamous cell carcinoma who previously received fluoropyrimidine- and platinum-based chemotherapy. Cancer Chemother Pharmacol. 2014;74:1207-15 pubmed publisher

Bonev V, Evangelista M, Chen J, Su M, Lane K, Mehta R, et al. Long-term follow-up of breast-conserving therapy in patients with inflammatory breast cancer treated with neoadjuvant chemotherapy. Am Surg. 2014;80:940-3 pubmed

Shimizu R, Fujimoto D, Kato R, Otoshi T, Kawamura T, Tamai K, et al. The safety and efficacy of paclitaxel and carboplatin with or without bevacizumab for treating patients with advanced nonsquamous non-small cell lung cancer with interstitial lung disease. Cancer Chemother Pharmacol. 2014;74:1159-66 pubmed publisher

Narui K, Ishikawa T, Satake T, Adachi S, Yamada A, Shimada K, et al. Outcomes of immediate perforator flap reconstruction after skin-sparing mastectomy following neoadjuvant chemotherapy. Eur J Surg Oncol. 2015;41:94-9 pubmed publisher

Liu T, Lo H, Wei L, Hsiao H, Yang P. S-Adenosyl-L-methionine-competitive inhibitors of the histone methyltransferase EZH2 induce autophagy and enhance drug sensitivity in cancer cells. Anticancer Drugs. 2015;26:139-47 pubmed publisher

Bozza W, Di X, Takeda K, Rivera Rosado L, Pariser S, Zhang B. The use of a stably expressed FRET biosensor for determining the potency of cancer drugs. PLoS ONE. 2014;9:e107010 pubmed publisher

Spedden E, Wiens M, Demirel M, Staii C. Effects of surface asymmetry on neuronal growth. PLoS ONE. 2014;9:e106709 pubmed publisher

Yu H, Lee H, Yun S, Lee S, Langley R, Yoon Y, et al. Antiangiogenic Therapy with Human Apolipoprotein(a) Kringle V and Paclitaxel in a Human Ovarian Cancer Mouse Model. Transl Oncol. 2014;7:368-76 pubmed publisher

Lin Y, Chen B, Lai W, Wu S, Guh J, Cheng A, et al. The Akt inhibitor MK-2206 enhances the cytotoxicity of paclitaxel (Taxol) and cisplatin in ovarian cancer cells. Naunyn Schmiedebergs Arch Pharmacol. 2015;388:19-31 pubmed publisher

Rajput S, Kumar B, Banik P, Parida S, Mandal M. Thymoquinone restores radiation-induced TGF-β expression and abrogates EMT in chemoradiotherapy of breast cancer cells. J Cell Physiol. 2015;230:620-9 pubmed publisher

Zong C, Wang J, Shi T. MicroRNA 130b enhances drug resistance in human ovarian cancer cells. Tumour Biol. 2014;35:12151-6 pubmed publisher

Groebner J, Fernandez D, Tuma D, Tuma P. Alcohol-induced defects in hepatic transcytosis may be explained by impaired dynein function. Mol Cell Biochem. 2014;397:223-33 pubmed publisher

Guerra E, Byrne R, Kastrati A. Pharmacological inhibition of coronary restenosis: systemic and local approaches. Expert Opin Pharmacother. 2014;15:2155-71 pubmed publisher

Miki M, Matsuo Y, Yoshida S, Tane K, Hirokaga K, Maekawa Y, et al. [A case of locally advanced and metastatic breast cancer successfully treated with combination therapy of paclitaxel and bevacizumab]. Gan To Kagaku Ryoho. 2014;41:1027-9 pubmed

Ouchi A, Asano M, Aono K, Watanabe T, Kato T. [A patient with paclitaxel hypersensitivity treated with nab-paclitaxel]. Gan To Kagaku Ryoho. 2014;41:889-91 pubmed

Hirano M, Ozamoto Y, Ichinose M, Togawa T, Takao N, Mizumoto A, et al. [A case of gastric adenosquamous carcinoma with peritoneal dissemination in which treatment with S-1 plus paclitaxel therapy resulted in improved long-term survival]. Gan To Kagaku Ryoho. 2014;41:885-8 pubmed

Delle Monache S, Sanità P, Calgani A, Schenone S, Botta L, Angelucci A. Src inhibition potentiates antitumoral effect of paclitaxel by blocking tumor-induced angiogenesis. Exp Cell Res. 2014;328:20-31 pubmed publisher

Calastretti A, Gatti G, Quaresmini C, Bevilacqua A. Down-modulation of Bcl-2 sensitizes PTEN-mutated prostate cancer cells to starvation and taxanes. Prostate. 2014;74:1411-22 pubmed publisher

Chaudhri R, Hadadi A, Lobachev K, Schwartz Z, Boyan B. Estrogen receptor-alpha 36 mediates the anti-apoptotic effect of estradiol in triple negative breast cancer cells via a membrane-associated mechanism. Biochim Biophys Acta. 2014;1843:2796-806 pubmed publisher

Jeganathan S, Fiorino C, Naik U, Sun H, Harrison R. Modulation of osteoclastogenesis with macrophage M1- and M2-inducing stimuli. PLoS ONE. 2014;9:e104498 pubmed publisher

Kurobe M, Kawai K, Oikawa T, Ichioka D, Kandori S, Takaoka E, et al. Paclitaxel, ifosfamide, and cisplatin (TIP) as salvage and consolidation chemotherapy for advanced germ cell tumor. J Cancer Res Clin Oncol. 2015;141:127-33 pubmed publisher

Chiotaki R, Polioudaki H, Theodoropoulos P. Differential nuclear shape dynamics of invasive andnon-invasive breast cancer cells are associated with actin cytoskeleton organization and stability. Biochem Cell Biol. 2014;92:287-95 pubmed publisher

Tian X, Qian D, He L, Huang H, Mai S, Li C, et al. The telomere/telomerase binding factor PinX1 regulates paclitaxel sensitivity depending on spindle assembly checkpoint in human cervical squamous cell carcinomas. Cancer Lett. 2014;353:104-14 pubmed publisher

Westin J, McLaughlin P, Romaguera J, Hagemeister F, Pro B, Dang N, et al. Paclitaxel, topotecan and rituximab: long term outcomes of an effective salvage programme for relapsed or refractory aggressive B-cell non-Hodgkin lymphoma. Br J Haematol. 2014;167:177-84 pubmed publisher

Diaz Martinez L, Karamysheva Z, Warrington R, Li B, Wei S, Xie X, et al. Genome-wide siRNA screen reveals coupling between mitotic apoptosis and adaptation. EMBO J. 2014;33:1960-76 pubmed publisher

Zou Z, Zhang J, Zhang H, Liu H, Li Z, Cheng D, et al. 3-Methyladenine can depress drug efflux transporters via blocking the PI3K-AKT-mTOR pathway thus sensitizing MDR cancer to chemotherapy. J Drug Target. 2014;22:839-48 pubmed publisher

Bi W, Wang Y, Sun G, Zhang X, Wei Y, Li L, et al. Paclitaxel-resistant HeLa cells have up-regulated levels of reactive oxygen species and increased expression of taxol resistance gene 1. Pak J Pharm Sci. 2014;27:871-8 pubmed

Kim S, Choi H, Lee H, He J, Wu Q, Langley R, et al. Role of the endothelin axis in astrocyte- and endothelial cell-mediated chemoprotection of cancer cells. Neuro Oncol. 2014;16:1585-98 pubmed publisher

Sumigray K, Zhou K, Lechler T. Cell-cell adhesions and cell contractility are upregulated upon desmosome disruption. PLoS ONE. 2014;9:e101824 pubmed publisher

Li N, Sun C, Zhou B, Xing H, Ma D, Chen G, et al. Low concentration of quercetin antagonizes the cytotoxic effects of anti-neoplastic drugs in ovarian cancer. PLoS ONE. 2014;9:e100314 pubmed publisher

McKiernan J, Holder D, Ghandour R, Barlow L, Ahn J, Kates M, et al. Phase II trial of intravesical nanoparticle albumin bound paclitaxel for the treatment of nonmuscle invasive urothelial carcinoma of the bladder after bacillus Calmette-Guérin treatment failure. J Urol. 2014;192:1633-8 pubmed publisher

Lyu X, Huang J, Mao Y, Liu Y, Feng Q, Shao K, et al. Adjuvant chemotherapy after esophagectomy: is there a role in the treatment of the lymph node positive thoracic esophageal squamous cell carcinoma?. J Surg Oncol. 2014;110:864-8 pubmed publisher

Ray S, Fanti J, Macedo D, Larsen M. LIM kinase regulation of cytoskeletal dynamics is required for salivary gland branching morphogenesis. Mol Biol Cell. 2014;25:2393-407 pubmed publisher

Feng S, Li J, Luo Y, Yin T, Cai H, Wang Y, et al. pH-sensitive nanomicelles for controlled and efficient drug delivery to human colorectal carcinoma LoVo cells. PLoS ONE. 2014;9:e100732 pubmed publisher

Tsuburaya A, Yoshida K, Kobayashi M, Yoshino S, Takahashi M, Takiguchi N, et al. Sequential paclitaxel followed by tegafur and uracil (UFT) or S-1 versus UFT or S-1 monotherapy as adjuvant chemotherapy for T4a/b gastric cancer (SAMIT): a phase 3 factorial randomised controlled trial. Lancet Oncol. 2014;15:886-93 pubmed publisher

Petrillo M, Zannoni G, Tortorella L, Pedone Anchora L, Salutari V, Ercoli A, et al. Prognostic role and predictors of complete pathologic response to neoadjuvant chemotherapy in primary unresectable ovarian cancer. Am J Obstet Gynecol. 2014;211:632.e1-8 pubmed publisher

Monk B, Poveda A, Vergote I, Raspagliesi F, Fujiwara K, Bae D, et al. Anti-angiopoietin therapy with trebananib for recurrent ovarian cancer (TRINOVA-1): a randomised, multicentre, double-blind, placebo-controlled phase 3 trial. Lancet Oncol. 2014;15:799-808 pubmed publisher

Lin W, Kao L. Cytotoxic enhancement of hexapeptide-conjugated micelles in EGFR high-expressed cancer cells. Expert Opin Drug Deliv. 2014;11:1537-50 pubmed publisher

Wang Y, Kathawala R, Zhang Y, Patel A, Kumar P, Shukla S, et al. Motesanib (AMG706), a potent multikinase inhibitor, antagonizes multidrug resistance by inhibiting the efflux activity of the ABCB1. Biochem Pharmacol. 2014;90:367-78 pubmed publisher

Statkiewicz M, Maryan N, Lipiec A, Grecka E, Grygorowicz M, Omiotek M, et al. The role of the SHH gene in prostate cancer cell resistance to paclitaxel. Prostate. 2014;74:1142-52 pubmed publisher

Liu B, Meng D, Wei T, Zhang S, Hu Y, Wang M. Apoptosis and pro-inflammatory cytokine response of mast cells induced by influenza A viruses. PLoS ONE. 2014;9:e100109 pubmed publisher

Ishizuna K, Ninomiya J, Ogawa T, Kojima M, Kawashima M, Nozaki M, et al. Locally advanced breast cancer with bleeding - two cases effectively treated with bevacizumab plus weekly paclitaxel. Gan To Kagaku Ryoho. 2014;41:637-40 pubmed

Yagi Y, Maeda T, Yoshimitsu Y, Sakuma H. [A case of breast cancer treated with chemotherapy after resection of giant ovarian metastasis]. Gan To Kagaku Ryoho. 2014;41:633-5 pubmed

Lai C, Saxena V, Tseng C, Jeng K, Kohara M, Lai M. Nonstructural protein 5A is incorporated into hepatitis C virus low-density particle through interaction with core protein and microtubules during intracellular transport. PLoS ONE. 2014;9:e99022 pubmed publisher

Zhang H, Zhang Y, Wang Y, Kathawala R, Patel A, Zhu H, et al. WHI-P154 enhances the chemotherapeutic effect of anticancer agents in ABCG2-overexpressing cells. Cancer Sci. 2014;105:1071-8 pubmed publisher

Lyi S, Tan M, Parrish C. Parvovirus particles and movement in the cellular cytoplasm and effects of the cytoskeleton. Virology. 2014;456-457:342-52 pubmed publisher

Langer C, Novello S, Park K, Krzakowski M, Karp D, Mok T, et al. Randomized, phase III trial of first-line figitumumab in combination with paclitaxel and carboplatin versus paclitaxel and carboplatin alone in patients with advanced non-small-cell lung cancer. J Clin Oncol. 2014;32:2059-66 pubmed publisher

Nakagawa M, Otake H, Shinke T, Takaya T, Kozuki A, Hariki H, et al. Analysis by optical coherence tomography of long-term arterial healing after implantation of different types of stents. Can J Cardiol. 2014;30:904-11 pubmed publisher

Lavi S, Camuglia A. Illuminating and alarming insights into vascular healing. Can J Cardiol. 2014;30:855-7 pubmed publisher

. Lapatinib plus paclitaxel versus paclitaxel alone in the second-line treatment of HER2-amplified advanced gastric cancer in Asian populations: TyTAN--a randomized, phase III study. J Clin Oncol. 2014;32:2039-49 pubmed publisher

Barcenas C, Niu J, Zhang N, Zhang Y, Buchholz T, Elting L, et al. Risk of hospitalization according to chemotherapy regimen in early-stage breast cancer. J Clin Oncol. 2014;32:2010-7 pubmed publisher

Sinnott R, Winters L, Larson B, Mytsa D, Taus P, Cappell K, et al. Mechanisms promoting escape from mitotic stress-induced tumor cell death. Cancer Res. 2014;74:3857-69 pubmed publisher

Kinoshita J, Fushida S, Tsukada T, Oyama K, Watanabe T, Shoji M, et al. Comparative study of the antitumor activity of Nab-paclitaxel and intraperitoneal solvent-based paclitaxel regarding peritoneal metastasis in gastric cancer. Oncol Rep. 2014;32:89-96 pubmed publisher

Pillai R, Aisner J, Dahlberg S, Rogers J, DiPaola R, Aisner S, et al. Interferon alpha plus 13-cis-retinoic acid modulation of BCL-2 plus paclitaxel for recurrent small-cell lung cancer (SCLC): an Eastern Cooperative Oncology Group study (E6501). Cancer Chemother Pharmacol. 2014;74:177-83 pubmed publisher

Peng T, Wu J, Tong L, Li M, Chen F, Leng Y, et al. Identification of DW532 as a novel anti-tumor agent targeting both kinases and tubulin. Acta Pharmacol Sin. 2014;35:916-28 pubmed publisher

Chen C, Hsieh D, Huang K, Chan Y, Hong P, Yeh M, et al. Improving anticancer efficacy of (-)-epigallocatechin-3-gallate gold nanoparticles in murine B16F10 melanoma cells. Drug Des Devel Ther. 2014;8:459-74 pubmed publisher

Ménard L, Parker P, Kermorgant S. Receptor tyrosine kinase c-Met controls the cytoskeleton from different endosomes via different pathways. Nat Commun. 2014;5:3907 pubmed publisher

Kurtyka C, Chen L, Cress W. E2F inhibition synergizes with paclitaxel in lung cancer cell lines. PLoS ONE. 2014;9:e96357 pubmed publisher

Kim J, Nagami S, Lee K, Park S. Characterization of microtubule-binding and dimerization activity of Giardia lamblia end-binding 1 protein. PLoS ONE. 2014;9:e97850 pubmed publisher

Jary M, Ghiringhelli F, Jacquin M, Fein F, Nguyen T, Cleau D, et al. Phase II multicentre study of efficacy and feasibility of dose-intensified preoperative weekly cisplatin, epirubicin, and paclitaxel (PET) in resectable gastroesophageal cancer. Cancer Chemother Pharmacol. 2014;74:141-50 pubmed publisher

Wilkinson Ryan I, Binder P, Pourabolghasem S, al Hammadi N, Fuh K, Hagemann A, et al. Concomitant chemotherapy and radiation for the treatment of advanced-stage endometrial cancer. Gynecol Oncol. 2014;134:24-8 pubmed publisher

Georges E, Lian J, Laberge R. A tamoxifen derivative, N,N-diethyl-2-[4-(phenylmethyl) phenoxy] ethanamine, selectively targets P-glycoprotein-positive multidrug resistant Chinese hamster cells. Biochem Pharmacol. 2014;90:107-14 pubmed publisher

Horinouchi H, Yamamoto N, Nokihara H, Horai T, Nishio M, Ohyanagi F, et al. A phase 1 study of linifanib in combination with carboplatin/paclitaxel as first-line treatment of Japanese patients with advanced or metastatic non-small cell lung cancer (NSCLC). Cancer Chemother Pharmacol. 2014;74:37-43 pubmed publisher

Lan Z, Lyu Y, Xiao J, Zheng X, He S, Feng G, et al. Novel biodegradable drug-eluting stent composed of poly-L-lactic acid and amorphous calcium phosphate nanoparticles demonstrates improved structural and functional performance for coronary artery disease. J Biomed Nanotechnol. 2014;10:1194-204 pubmed

Gwe Ahn S, Ah Lee S, Woo Lee H, Min Lee H, Jeong J. In vitro chemoresponse assay based on the intrinsic subtypes in breast cancer. Jpn J Clin Oncol. 2014;44:624-31 pubmed publisher

Nieuweboer A, Hu S, Gui C, Hagenbuch B, Ghobadi Moghaddam Helmantel I, Gibson A, et al. Influence of drug formulation on OATP1B-mediated transport of paclitaxel. Cancer Res. 2014;74:3137-45 pubmed publisher

Liu Y, Liu C, Li M, Liu F, Feng L, Zhang L, et al. Polymer-polymer conjugation to fabricate multi-block polymer as novel drug carriers: poly(lactic acid)-poly(ethylene glycol)-poly(L-lysine) to enhance paclitaxel target delivery. J Biomed Nanotechnol. 2014;10:948-58 pubmed

Mäki Jouppila J, Laine L, Rehnberg J, Narvi E, Tiikkainen P, Hukasova E, et al. Centmitor-1, a novel acridinyl-acetohydrazide, possesses similar molecular interaction field and antimitotic cellular phenotype as rigosertib, on 01910.Na. Mol Cancer Ther. 2014;13:1054-66 pubmed publisher

Yang X, Xu W, Hu Z, Zhang Y, Xu N. Chk1 is required for the metaphase-anaphase transition via regulating the expression and localization of Cdc20 and Mad2. Life Sci. 2014;106:12-8 pubmed publisher

Dolfi S, Jäger A, Medina D, Haffty B, Yang J, Hirshfield K. Fulvestrant treatment alters MDM2 protein turnover and sensitivity of human breast carcinoma cells to chemotherapeutic drugs. Cancer Lett. 2014;350:52-60 pubmed publisher

Noma M, Ohara M, Imaoka Y, Mashima H, Mizota S, Okimoto S, et al. [A case of triple-negative breast cancer responding to multidisciplinary treatment containing bevacizumab]. Gan To Kagaku Ryoho. 2014;41:483-6 pubmed

Tang Y, Xue Y, Zhou L, Zhang J, Yao G, Luo Z, et al. New norclerodane diterpenoids from the tubers of Dioscorea bulbifera. Chem Pharm Bull (Tokyo). 2014;62:719-24 pubmed

Shiota M, Itsumi M, Yokomizo A, Takeuchi A, Imada K, Kashiwagi E, et al. Targeting ribosomal S6 kinases/Y-box binding protein-1 signaling improves cellular sensitivity to taxane in prostate cancer. Prostate. 2014;74:829-38 pubmed publisher

Peng Y, Li Z, Zhang S, Xiong Y, Cun Y, Qian C, et al. Association of DNA base excision repair genes (OGG1, APE1 and XRCC1) polymorphisms with outcome to platinum-based chemotherapy in advanced nonsmall-cell lung cancer patients. Int J Cancer. 2014;135:2687-96 pubmed publisher

Shusharina N, Cho J, Sharp G, Choi N. Correlation of (18)F-FDG avid volumes on pre-radiation therapy and post-radiation therapy FDG PET scans in recurrent lung cancer. Int J Radiat Oncol Biol Phys. 2014;89:137-44 pubmed publisher

Oyama T, Takeuchi H, Matsuda S, Ozawa S, Kitajima M, Kitagawa Y. Translymphatic chemotherapy targeting sentinel lymph nodes using a novel phospholipid polymer-Paclitaxel conjugate. Anticancer Res. 2014;34:1751-7 pubmed

Stockler M, Hilpert F, Friedlander M, King M, Wenzel L, Lee C, et al. Patient-reported outcome results from the open-label phase III AURELIA trial evaluating bevacizumab-containing therapy for platinum-resistant ovarian cancer. J Clin Oncol. 2014;32:1309-16 pubmed publisher

Kapur M, Maloney M, Wang W, Chen X, Millan I, Mooney T, et al. A SxIP motif interaction at the microtubule plus end is important for processive retrograde axonal transport. Cell Mol Life Sci. 2014;71:4043-54 pubmed publisher

Correa R, Krajewska M, Ware C, Gerlic M, Reed J. The NLR-related protein NWD1 is associated with prostate cancer and modulates androgen receptor signaling. Oncotarget. 2014;5:1666-82 pubmed

Zhu H, Liao S, Shi J, Chang L, Tong Y, Cao J, et al. DJ-1 mediates the resistance of cancer cells to dihydroartemisinin through reactive oxygen species removal. Free Radic Biol Med. 2014;71:121-32 pubmed publisher

Au Yeung G, Webb P, deFazio A, Fereday S, Bressel M, Mileshkin L. Impact of obesity on chemotherapy dosing for women with advanced stage serous ovarian cancer in the Australian Ovarian Cancer Study (AOCS). Gynecol Oncol. 2014;133:16-22 pubmed publisher

Slaughter K, Thai T, Penaroza S, Benbrook D, Thavathiru E, Ding K, et al. Measurements of adiposity as clinical biomarkers for first-line bevacizumab-based chemotherapy in epithelial ovarian cancer. Gynecol Oncol. 2014;133:11-5 pubmed publisher

Hamid O, Ilaria R, Garbe C, Wolter P, Maio M, Hutson T, et al. A randomized, open-label clinical trial of tasisulam sodium versus paclitaxel as second-line treatment in patients with metastatic melanoma. Cancer. 2014;120:2016-24 pubmed publisher

Leopardi M, Houbballah R, Becquemin J. Effectiveness of Zilver PTX eluting stent in TASC C/D lesions and restenosis. J Cardiovasc Surg (Torino). 2014;55:229-34 pubmed

Kitrou P, Parthipun A, Diamantopoulos A, Padayachee S, Karunanithy N, Ahmed I, et al. Paclitaxel-coated balloons for failing peripheral bypass grafts: the BYPACS study. J Cardiovasc Surg (Torino). 2014;55:217-24 pubmed

Soares A, Costa V, Diniz C, Fresco P. Combination of Cl‑IB‑MECA with paclitaxel is a highly effective cytotoxic therapy causing mTOR‑dependent autophagy and mitotic catastrophe on human melanoma cells. J Cancer Res Clin Oncol. 2014;140:921-35 pubmed

Cheng H, Ko F. Studying the enhancement of programmed cell death by combined AG1024 and paclitaxel in a model of chronic myelogenous leukemia. Life Sci. 2014;102:118-26 pubmed publisher

Morichika D, Sato Hisamoto A, Hotta K, Takata K, Iwaki N, Uchida K, et al. Fatal Candida septic shock during systemic chemotherapy in lung cancer patient receiving corticosteroid replacement therapy for hypopituitarism: a case report. Jpn J Clin Oncol. 2014;44:501-5 pubmed publisher

Yang Q, Huang J, Wu Q, Cai Y, Zhu L, Lu X, et al. Acquisition of epithelial-mesenchymal transition is associated with Skp2 expression in paclitaxel-resistant breast cancer cells. Br J Cancer. 2014;110:1958-67 pubmed publisher

Pujade Lauraine E, Hilpert F, Weber B, Reuss A, Poveda A, Kristensen G, et al. Bevacizumab combined with chemotherapy for platinum-resistant recurrent ovarian cancer: The AURELIA open-label randomized phase III trial. J Clin Oncol. 2014;32:1302-8 pubmed publisher

Shi S, Tao L, Song H, Chen L, Huang G. Synergistic antitumor effect of combining metronomic chemotherapy with adoptive cell immunotherapy in nude mice. APMIS. 2014;122:380-91 pubmed publisher

Sonobe S, Inoue K, Tachibana S, Shiojiri M, Maeda T, Nakanishi N, et al. A case of pulmonary mucoepidermoid carcinoma responding to carboplatin and paclitaxel. Jpn J Clin Oncol. 2014;44:493-6 pubmed publisher

Vizza E, Corrado G, Zanagnolo V, Tomaselli T, Cutillo G, Mancini E, et al. Neoadjuvant chemotherapy followed by robotic radical hysterectomy in locally advanced cervical cancer: a multi-institution study. Gynecol Oncol. 2014;133:180-5 pubmed publisher

Kim J, Jang M, Jin D, Chung Y, Choi B, Park G, et al. Paclitaxel-exposed ovarian cancer cells induce cancer?specific CD4+ T cells after doxorubicin exposure through regulation of MyD88 expression. Int J Oncol. 2014;44:1716-26 pubmed publisher

Wang X, Huang C, Li M, Gu Y, Cui Y, Li Y. The efficacy of bevacizumab plus paclitaxel as first-line treatment for HER2-negative metastatic breast cancer: a meta-analysis of randomized controlled trials. Tumour Biol. 2014;35:4841-8 pubmed publisher

Jakobsen J, Santoni Rugiu E, Sørensen J. Thymidylate synthase protein expression levels remain stable during paclitaxel and carboplatin treatment in non-small cell lung cancer. J Cancer Res Clin Oncol. 2014;140:645-52 pubmed publisher

Bradford L, Rauh Hain A, Clark R, Groeneweg J, Zhang L, BORGER D, et al. Assessing the efficacy of targeting the phosphatidylinositol 3-kinase/AKT/mTOR signaling pathway in endometrial cancer. Gynecol Oncol. 2014;133:346-52 pubmed publisher

Megerdichian C, Olimpiadi Y, Hurvitz S. nab-Paclitaxel in combination with biologically targeted agents for early and metastatic breast cancer. Cancer Treat Rev. 2014;40:614-25 pubmed publisher

Tewari K, Sill M, Long H, Penson R, Huang H, Ramondetta L, et al. Improved survival with bevacizumab in advanced cervical cancer. N Engl J Med. 2014;370:734-43 pubmed publisher

Krivak T, Lele S, Richard S, Secord A, Leath C, Brower S, et al. A chemoresponse assay for prediction of platinum resistance in primary ovarian cancer. Am J Obstet Gynecol. 2014;211:68.e1-8 pubmed publisher

Zhu X, Li Y, Xie C, Yin X, Liu Y, Cao Y, et al. miR-145 sensitizes ovarian cancer cells to paclitaxel by targeting Sp1 and Cdk6. Int J Cancer. 2014;135:1286-96 pubmed publisher

Perkins J, Hong Y, Ye S, Wagner W, Desai S. Direct writing of bio-functional coatings for cardiovascular applications. J Biomed Mater Res A. 2014;102:4290-300 pubmed publisher

Lorusso D, Petrelli F, Coinu A, Raspagliesi F, Barni S. A systematic review comparing cisplatin and carboplatin plus paclitaxel-based chemotherapy for recurrent or metastatic cervical cancer. Gynecol Oncol. 2014;133:117-23 pubmed publisher

Saltz L, Bach P. Albumin-bound paclitaxel plus gemcitabine in pancreatic cancer. N Engl J Med. 2014;370:478 pubmed publisher

Von Hoff D, Goldstein D, Renschler M. Albumin-bound paclitaxel plus gemcitabine in pancreatic cancer. N Engl J Med. 2014;370:479-80 pubmed publisher

Groo A, Mircheva K, Béjaud J, Ailhas C, Panaiotov I, Saulnier P, et al. Development of 2D and 3D mucus models and their interactions with mucus-penetrating paclitaxel-loaded lipid nanocapsules. Pharm Res. 2014;31:1753-65 pubmed publisher

Ojeda Lopez M, Needleman D, Song C, Ginsburg A, Kohl P, Li Y, et al. Transformation of taxol-stabilized microtubules into inverted tubulin tubules triggered by a tubulin conformation switch. Nat Mater. 2014;13:195-203 pubmed publisher

Nakajima T, Taniwaka K, Yoshioka T, Abe S, Kamei T, Goto H. [A case of carcinomatous cardiac tamponade caused by breast cancer treated with instillation of paclitaxel and minocycline]. Gan To Kagaku Ryoho. 2014;41:87-9 pubmed

Hayashi K, Enomoto T, Oshida S, Habiro T, Hatate K, Sengoku N, et al. [A patient with thyroid cancer evaluated according to Response Evaluation Criteria in Solid Tumors during treatment for breast cancer recurrence in hepatic and cervical lymph nodes]. Gan To Kagaku Ryoho. 2013;40:2423-6 pubmed

Aomatsu N, Kashiwagi S, Morisaki T, Ishihara S, Asano Y, Watanabe M, et al. [Usefulness of bevacizumab combination chemotherapy for advanced breast cancer]. Gan To Kagaku Ryoho. 2013;40:2393-5 pubmed

Sato Y, Nakagawa T, Sato T, Nagahara M, Sugihara K. [A case of recurrent breast cancer with carcinomatous pleurisy responding to bevacizumab and paclitaxel therapy]. Gan To Kagaku Ryoho. 2013;40:2387-9 pubmed

Kashiwagi S, Ishihara S, Ishii M, Asano Y, Watanabe M, Morisaki T, et al. [Case of a patient with inflammatory breast cancer who responded to preoperative chemotherapy with paclitaxel plus bevacizumab and could subsequently undergo surgery]. Gan To Kagaku Ryoho. 2013;40:2384-6 pubmed

Minatani N, Kosaka Y, Sengoku N, Kikuchi M, Nishimiya H, Waraya M, et al. [A case of facial nerve palsy induced by nab-paclitaxel]. Gan To Kagaku Ryoho. 2013;40:2375-7 pubmed

Mizuyama Y, Shinto O, Tamura T, Nakagawa H, Ohno Y, Takashima T, et al. [A case of solitary adrenal metastasis from breast cancer successfully resected by laparoscopy]. Gan To Kagaku Ryoho. 2013;40:2351-3 pubmed

Yokosuka T, Enomoto T, Takeda A, Kobayashi T. [Locally advanced granulocyte colony-stimulating factor-producing non-small cell lung cancer successfully treated with concurrent chemoradiotherapy]. Gan To Kagaku Ryoho. 2013;40:2330-2 pubmed

Kimura A, Kawasaki H, Wajima N, Nakai M, Nakayama Y, Yonaiyama S, et al. [A case of rapidly fatal gastric cancer with disseminated carcinomatosis of the bone marrow]. Gan To Kagaku Ryoho. 2013;40:2322-4 pubmed

Sasaki K, Fujiwara Y, Kishi K, Motoori M, Sugimura K, Miyoshi N, et al. [Repeated occlusion of the intraperitoneal access port for intraperitoneal chemotherapy in a patient with gastric cancer with peritoneal dissemination]. Gan To Kagaku Ryoho. 2013;40:2319-21 pubmed

Kato R, Okada K, Ebisui C, Wada Y, Makino S, Takeoka T, et al. [A case of unresectable gastric cancer in a patient who maintained a good quality of life with multidisciplinary treatment]. Gan To Kagaku Ryoho. 2013;40:2280-2 pubmed

Shirai J, Cho H, Fujikawa H, Iwasaki K, Ogata T, Yoshikawa T, et al. [A case of rectal stenosis due to peritoneal dissemination from gastric cancer that was treated with chemoradiation therapy]. Gan To Kagaku Ryoho. 2013;40:2268-70 pubmed

Nishikawa K, Iwase K, Aono T, Yoshida H, Nomura M, Tamagawa H, et al. [A case of paclitaxel-resistant recurrent gastric cancer responsive to S-1 plus docetaxel]. Gan To Kagaku Ryoho. 2013;40:2259-61 pubmed

Kudoh K, Ogata K, Narita Y, Ohchi T. [A case of gastric cancer treated with chemotherapy with weekly paclitaxel and expandable metallic stent placement that resulted in long-term quality of life]. Gan To Kagaku Ryoho. 2013;40:2226-8 pubmed

Nagahama T, Ando M, Seki R, Fujiya K, Amagasa H, Takasaki J, et al. [Preoperative chemotherapy for advanced gastric cancer]. Gan To Kagaku Ryoho. 2013;40:2217-9 pubmed

Kawada J, Nishimura M, Matsui Y, Nomura M, Noguchi Y, Okumura Y, et al. [Analysis of weekly paclitaxel chemotherapy for esophageal cancer]. Gan To Kagaku Ryoho. 2013;40:2118-20 pubmed

Rodes Cabau J, Bertrand O, Larose E, Dery J, Rinfret S, Urena M, et al. Five-year follow-up of the plaque sealing with paclitaxel-eluting stents vs medical therapy for the treatment of intermediate nonobstructive saphenous vein graft lesions (VELETI) trial. Can J Cardiol. 2014;30:138-45 pubmed publisher

Ravo V, Falivene S, De Chiara A, DE Palma G, Pizzolorusso A, Di Franco R, et al. Treatment of cutaneous angiosarcoma of the face: efficacy of combined chemotherapy and radiotherapy. Tumori. 2013;99:e211-5 pubmed publisher

Itamochi H, Nishimura M, Oumi N, Kato M, Oishi T, Shimada M, et al. Checkpoint kinase inhibitor AZD7762 overcomes cisplatin resistance in clear cell carcinoma of the ovary. Int J Gynecol Cancer. 2014;24:61-9 pubmed publisher

Watanabe K, Shinkai M, Goto H, Yoshikawa S, Yamaguchi N, Hara Y, et al. Chemotherapy with carboplatin and paclitaxel after failure of primary chemotherapy for advanced thymic carcinoma. A report of three cases and review of the literature. Tumori. 2013;99:e172-6 pubmed publisher

Le Moulec S, Hadoux J, Gontier E, Chargari C, Helissey C, Lamand V, et al. Combination of paclitaxel and bevacizumab in heavily pre-treated non-small-cell lung cancer (NSCLC) patients: a case series study on 15 patients. Bull Cancer. 2013;100:30-7 pubmed publisher

Furuse J. [Current status and future directions of chemotherapy for pancreatic cancer]. Nihon Shokakibyo Gakkai Zasshi. 2013;110:2060-5 pubmed

Brener S, Kereiakes D, Simonton C, Rizvi A, Newman W, Mastali K, et al. Everolimus-eluting stents in patients undergoing percutaneous coronary intervention: final 3-year results of the Clinical Evaluation of the XIENCE V Everolimus Eluting Coronary Stent System in the Treatment of Subjects With de Novo Native Coronary Ar. Am Heart J. 2013;166:1035-42 pubmed publisher

Shen J, Meng Q, Sui H, Yin Q, Zhang Z, Yu H, et al. iRGD conjugated TPGS mediates codelivery of paclitaxel and survivin shRNA for the reversal of lung cancer resistance. Mol Pharm. 2014;11:2579-91 pubmed publisher

Frédéric M, Lundin V, Whiteside M, Cueva J, Tu D, Kang S, et al. Identification of 526 conserved metazoan genetic innovations exposes a new role for cofactor E-like in neuronal microtubule homeostasis. PLoS Genet. 2013;9:e1003804 pubmed publisher

Kadam A, Najlah M, Wan K, Ahmed W, Crean S, Phoenix D, et al. Stability of parenteral nanoemulsions loaded with paclitaxel: the influence of lipid phase composition, drug concentration and storage temperature. Pharm Dev Technol. 2014;19:999-1004 pubmed publisher

Otsuka I, Takaya H, Takagi K, Tanaka A, Kaseki H, Izuta C, et al. [Carcinosarcoma of the ovary treated with paclitaxel and carboplatin chemotherapy - a report of 4 cases]. Gan To Kagaku Ryoho. 2013;40:1249-53 pubmed

Zhang H, Li H, Yang L, Deng Z, Luo H, Ye D, et al. The ClC-3 chloride channel associated with microtubules is a target of paclitaxel in its induced-apoptosis. Sci Rep. 2013;3:2615 pubmed publisher

Gornstein E, Schwarz T. The paradox of paclitaxel neurotoxicity: Mechanisms and unanswered questions. Neuropharmacology. 2014;76 Pt A:175-83 pubmed publisher

Bajaj M, Srayko M. Laulimalide induces dose-dependent modulation of microtubule behaviour in the C. elegans embryo. PLoS ONE. 2013;8:e71889 pubmed publisher

Sethi A, Sher M, Akram M, Karim S, Khiljee S, Sajjad A, et al. Albumin as a drug delivery and diagnostic tool and its market approved products. Acta Pol Pharm. 2013;70:597-600 pubmed

Ma W, Hidalgo M. The winning formulation: the development of paclitaxel in pancreatic cancer. Clin Cancer Res. 2013;19:5572-9 pubmed publisher

Friedman J, Wise S, Hu M, Gouveia C, Vander Broek R, Freudlsperger C, et al. HSP90 Inhibitor SNX5422/2112 Targets the Dysregulated Signal and Transcription Factor Network and Malignant Phenotype of Head and Neck Squamous Cell Carcinoma. Transl Oncol. 2013;6:429-41 pubmed

Zhu L, Zhang B, Lu X, Shu Y, Liu B. Delivery of paclitaxel and berbamine by polymeric carriers to cure gastric cancer. Oncol Res. 2013;20:265-74 pubmed

Liu J, Wetzel L, Zhang Y, Nagayasu E, Ems McClung S, Florens L, et al. Novel thioredoxin-like proteins are components of a protein complex coating the cortical microtubules of Toxoplasma gondii. Eukaryot Cell. 2013;12:1588-99 pubmed publisher

Yamamoto D, Tsubota Y, Sueoka N, Yokoi T, Inoue K, Ohira M, et al. [Comparison of a safety evaluation between paclitaxel injection NK and Taxol®]. Gan To Kagaku Ryoho. 2013;40:959-61 pubmed

Imamura T, Chujo S, Suzuki K, Iwama H, Kondo S, Suwa H, et al. [A case of long remission for about 5 years as an outpatient with second-line chemotherapy of weekly PTX after palliative distal gastrectomy for pStage IV advanced gastric cancer]. Gan To Kagaku Ryoho. 2013;40:925-7 pubmed

Kawamura M, Nakano S, Kyoda S, Tabei I, Yoshida K, Takeyama H. [Administration of low-dose albumin-bound paclitaxel for the treatment of advanced and recurrent breast cancer patients]. Gan To Kagaku Ryoho. 2013;40:909-12 pubmed

Noguchi Y, Nishimura R, Kawara H, Omori K, Matsumoto K, Tokuyama Y, et al. [Survey of current status of adverse ocular reactions to paclitaxel and a retrospective analysis for aiding in early detection of adverse reactions]. Gan To Kagaku Ryoho. 2013;40:819-22 pubmed

Morishita A, Mitsuhashi S, Fujisawa F, Hirano M, Kojima H. [Usefulness of bevacizumab with paclitaxel for advanced breast cancer - a case report]. Gan To Kagaku Ryoho. 2013;40:761-4 pubmed

Katayama K, Nishino T, Takahashi Y, Tanaka T, Okitsu H, Okitsu N. [Approximately four years of survival benefits for a case of gastric cancer postoperative carcinomatous peritonitis by combined modality therapy]. Gan To Kagaku Ryoho. 2013;40:655-8 pubmed

Yoshibayashi H, Ishiguro H, Kawaguchi K, Yamoto M, Nishimura T, Yamada H, et al. [A patient with primary breast cancer who responded remarkably well to neoadjuvant chemotherapy with FEC100 followed by Abraxane]. Gan To Kagaku Ryoho. 2013;40:627-9 pubmed

Saito M, Fujita S, Sakuma T, Matsuzaki M, Katagata N, Watanabe F, et al. [A case of triple-negative breast cancer achieved pCR by epirubicin and cyclophosphamide(EC)therapy followed by gemcitabine plus paclitaxel combination preoperative therapy]. Gan To Kagaku Ryoho. 2013;40:623-5 pubmed

Zhang J, Ma Z, Liu P, Ji Q, Qi J, Duan Y. Antitumor efficacy of paclitaxel-loaded polylactide/ poly(ethylene glycol) nanoparticles combination with exercise in tumor-bearing mice. J Nanosci Nanotechnol. 2013;13:3868-73 pubmed

Wang P, Chen J, Mu L, Du Q, Niu X, Zhang M. Propofol inhibits invasion and enhances paclitaxel- induced apoptosis in ovarian cancer cells through the suppression of the transcription factor slug. Eur Rev Med Pharmacol Sci. 2013;17:1722-9 pubmed

Hertz D. Germline pharmacogenetics of paclitaxel for cancer treatment. Pharmacogenomics. 2013;14:1065-84 pubmed publisher

Li L, Fothergill T, Hutchins B, Dent E, Kalil K. Wnt5a evokes cortical axon outgrowth and repulsive guidance by tau mediated reorganization of dynamic microtubules. Dev Neurobiol. 2014;74:797-817 pubmed publisher

Tang Y, Xie T, Florian S, Moerke N, SHAMU C, Benes C, et al. Differential determinants of cancer cell insensitivity to antimitotic drugs discriminated by a one-step cell imaging assay. J Biomol Screen. 2013;18:1062-71 pubmed publisher

Saito M, Yano K, Kamigaki T, Goto S. A patient with scirrhous stomach cancer treated with combination of hyperthermotherapy and 5-aminolevulinic acid (ALA). Anticancer Res. 2013;33:2957-63 pubmed

Mizobe T, Akagi Y, Ishikawa H, Shiratsuchi I, Oka Y, Kinugasa T, et al. Gemcitabine with paclitaxel therapy against mesocolic leiomyosarcoma: a case report. Anticancer Res. 2013;33:2929-33 pubmed

Shen Y, Wang P, Li Y, Ye F, Wang F, Wan X, et al. miR-375 is upregulated in acquired paclitaxel resistance in cervical cancer. Br J Cancer. 2013;109:92-9 pubmed publisher

Chen J, Pan J, Liu J, Li J, Zhu K, Zheng X, et al. Postoperative radiation therapy with or without concurrent chemotherapy for node-positive thoracic esophageal squamous cell carcinoma. Int J Radiat Oncol Biol Phys. 2013;86:671-7 pubmed publisher

Tien S, Chang Z. Oncogenic Shp2 disturbs microtubule regulation to cause HDAC6-dependent ERK hyperactivation. Oncogene. 2014;33:2938-46 pubmed publisher

Yardley D. nab-Paclitaxel mechanisms of action and delivery. J Control Release. 2013;170:365-72 pubmed publisher

Yoshino S, Furuya T, Shimizu R, Ozasa H, Nishimura T, Fukuda S, et al. Combination phase II study of weekly paclitaxel and 5'-DFUR for unresectable or recurrent gastric cancer. Anticancer Res. 2013;33:2629-33 pubmed

Kellokumpu Lehtinen P, Tuunanen T, Asola R, Elomaa L, Heikkinen M, Kokko R, et al. Weekly paclitaxel--an effective treatment for advanced breast cancer. Anticancer Res. 2013;33:2623-7 pubmed

Wu Y, Neuwelt A, Muldoon L, Neuwelt E. Acetaminophen enhances cisplatin- and paclitaxel-mediated cytotoxicity to SKOV3 human ovarian carcinoma. Anticancer Res. 2013;33:2391-400 pubmed

Favero G, Pfiffer T, Riedlinger W, Chiantera V, Schneider A. Uncommon synchronous association between ovarian carcinoma and gastrointestinal stromal tumor: a case study and literature review. Tumori. 2013;99:e70-2 pubmed publisher

Westeel V, Quoix E, Puyraveau M, Lavole A, Braun D, Laporte S, et al. A randomised trial comparing preoperative to perioperative chemotherapy in early-stage non-small-cell lung cancer (IFCT 0002 trial). Eur J Cancer. 2013;49:2654-64 pubmed publisher

Wong Y, Plimack E, Litwin S, Vaughn D, Lee J, Song W, et al. Reply to S. Buti and S. Culine. J Clin Oncol. 2013;31:1615-6 pubmed

Martin M, Ruiz A, Ruiz Borrego M, Barnadas A, Gonzalez S, Calvo L, et al. Fluorouracil, doxorubicin, and cyclophosphamide (FAC) versus FAC followed by weekly paclitaxel as adjuvant therapy for high-risk, node-negative breast cancer: results from the GEICAM/2003-02 study. J Clin Oncol. 2013;31:2593-9 pubmed publisher

Zhao Y, Su J, Goto M, Morris Natschke S, Li Y, Zhao Q, et al. Dual-functional abeo-taxane derivatives destabilizing microtubule equilibrium and inhibiting NF-κB activation. J Med Chem. 2013;56:4749-57 pubmed publisher

Damian S, Celio L, De Benedictis E, Mariani P, Agustoni F, Ricchini F, et al. Is a dexamethasone-sparing strategy capable of preventing acute and delayed emesis caused by combined doxorubicin and paclitaxel for breast cancer? Analysis of a phase II trial. Oncology. 2013;84:371-7 pubmed publisher

Werner M, Cummings N, Sethi M, Wang E, Sukumar R, Moore D, et al. Preclinical evaluation of Genexol-PM, a nanoparticle formulation of paclitaxel, as a novel radiosensitizer for the treatment of non-small cell lung cancer. Int J Radiat Oncol Biol Phys. 2013;86:463-468 pubmed publisher

Ko Y, Canil C, Mukherjee S, Winquist E, Elser C, Eisen A, et al. Nanoparticle albumin-bound paclitaxel for second-line treatment of metastatic urothelial carcinoma: a single group, multicentre, phase 2 study. Lancet Oncol. 2013;14:769-76 pubmed publisher

Sonpavde G, Galsky M, Bellmunt J. A new approach to second-line therapy for urothelial cancer?. Lancet Oncol. 2013;14:682-4 pubmed publisher

Dyer M, Richardson J, Robertson J, Adam J. NICE guidance on bevacizumab in combination with paclitaxel and carboplatin for the first-line treatment of advanced ovarian cancer. Lancet Oncol. 2013;14:689-90 pubmed publisher

Vecchione A, Belletti B, Lovat F, Volinia S, Chiappetta G, Giglio S, et al. A microRNA signature defines chemoresistance in ovarian cancer through modulation of angiogenesis. Proc Natl Acad Sci U S A. 2013;110:9845-50 pubmed publisher

Wang W, Yang Y, Zheng X, Huang S, Guo L, Kong J, et al. [The advance in synthetic biology: towards a microbe-derived paclitaxel intermediates]. Yao Xue Xue Bao. 2013;48:187-92 pubmed

Maor Nof M, Homma N, Raanan C, Nof A, Hirokawa N, Yaron A. Axonal pruning is actively regulated by the microtubule-destabilizing protein kinesin superfamily protein 2A. Cell Rep. 2013;3:971-7 pubmed publisher

Campos Parra A, Zuloaga C, Manríquez M, Aviles A, Borbolla Escoboza J, Cardona A, et al. KRAS mutation as the biomarker of response to chemotherapy and EGFR-TKIs in patients with advanced non-small cell lung cancer: clues for its potential use in second-line therapy decision making. Am J Clin Oncol. 2015;38:33-40 pubmed publisher

Palmerini E, Maki R, Staals E, Alberghini M, Antonescu C, Ferrari C, et al. Primary angiosarcoma of bone: a retrospective analysis of 60 patients from 2 institutions. Am J Clin Oncol. 2014;37:528-34 pubmed publisher

Gebhardt B, Mendenhall C, Morris C, Kirwan J, McAfee W, Mendenhall W. Radiotherapy alone or combined with chemotherapy for the treatment of squamous cell carcinoma of the base of the tongue. Am J Clin Oncol. 2014;37:535-8 pubmed publisher

Bocci G, Di Paolo A, Danesi R. The pharmacological bases of the antiangiogenic activity of paclitaxel. Angiogenesis. 2013;16:481-92 pubmed publisher

Refaat T, Choi M, Gaber G, Kiel K, Mehta M, Gradishar W, et al. Markov model and cost-effectiveness analysis of bevacizumab in HER2-negative metastatic breast cancer. Am J Clin Oncol. 2014;37:480-5 pubmed publisher

Jeyapalan S, Boxerman J, Donahue J, Goldman M, Kinsella T, DiPetrillo T, et al. Paclitaxel poliglumex, temozolomide, and radiation for newly diagnosed high-grade glioma: a Brown University Oncology Group Study. Am J Clin Oncol. 2014;37:444-9 pubmed publisher

Lipp H. [nab-Paclitaxel. Clinical value of an innovative taxane-containing formulation]. Med Monatsschr Pharm. 2013;36:14-24 pubmed

Zhang Z, Mei L, Feng S. Paclitaxel drug delivery systems. Expert Opin Drug Deliv. 2013;10:325-40 pubmed publisher

Qi W, Shen Z, Lin F, Sun Y, Min D, Tang L, et al. Paclitaxel-based versus docetaxel-based regimens in metastatic breast cancer: a systematic review and meta-analysis of randomized controlled trials. Curr Med Res Opin. 2013;29:117-25 pubmed publisher

Onrubia M, Cusido R, Ramirez K, Hernandez Vazquez L, Moyano E, Bonfill M, et al. Bioprocessing of plant in vitro systems for the mass production of pharmaceutically important metabolites: paclitaxel and its derivatives. Curr Med Chem. 2013;20:880-91 pubmed

Tawadros T, Alonso F, Jichlinski P, Clarke N, Calandra T, Haefliger J, et al. Release of macrophage migration inhibitory factor by neuroendocrine-differentiated LNCaP cells sustains the proliferation and survival of prostate cancer cells. Endocr Relat Cancer. 2013;20:137-49 pubmed publisher

Shah K, Gupta S, Ghosh J, Bajpai J, Maheshwari A. Acute non-ST elevation myocardial infarction following paclitaxel administration for ovarian carcinoma: a case report and review of literature. J Cancer Res Ther. 2012;8:442-4 pubmed publisher

Loh J, Waksman R. Paclitaxel drug-coated balloons: a review of current status and emerging applications in native coronary artery de novo lesions. JACC Cardiovasc Interv. 2012;5:1001-12 pubmed publisher

Koudelka S, Turanek J. Liposomal paclitaxel formulations. J Control Release. 2012;163:322-34 pubmed publisher

Funato M, Fukao T, Sasai H, Hori T, Terazawa D, Kanda K, et al. Paclitaxel-based chemotherapy for aggressive kaposiform hemangioendothelioma of the temporomastoid region: Case report and review of the literature. Head Neck. 2013;35:E258-61 pubmed publisher

Frese K, Neesse A, Cook N, Bapiro T, Lolkema M, Jodrell D, et al. nab-Paclitaxel potentiates gemcitabine activity by reducing cytidine deaminase levels in a mouse model of pancreatic cancer. Cancer Discov. 2012;2:260-269 pubmed publisher

Shao M, Lin Y, Liu Z, Zhang Y, Wang L, Liu C, et al. GSK-3 activity is critical for the orientation of the cortical microtubules and the dorsoventral axis determination in zebrafish embryos. PLoS ONE. 2012;7:e36655 pubmed publisher

Tegze B, Szallasi Z, Haltrich I, Pénzváltó Z, Tóth Z, Liko I, et al. Parallel evolution under chemotherapy pressure in 29 breast cancer cell lines results in dissimilar mechanisms of resistance. PLoS ONE. 2012;7:e30804 pubmed publisher

Sherman Baust C, Becker K, Wood Iii W, Zhang Y, Morin P. Gene expression and pathway analysis of ovarian cancer cells selected for resistance to cisplatin, paclitaxel, or doxorubicin. J Ovarian Res. 2011;4:21 pubmed publisher

Russell P, Hennessy B, Li J, Carey M, Bast R, Freeman T, et al. Cyclin G1 regulates the outcome of taxane-induced mitotic checkpoint arrest. Oncogene. 2012;31:2450-60 pubmed publisher

Mitra M, Kandalam M, Sundaram C, Verma R, Maheswari U, Swaminathan S, et al. Reversal of stathmin-mediated microtubule destabilization sensitizes retinoblastoma cells to a low dose of antimicrotubule agents: a novel synergistic therapeutic intervention. Invest Ophthalmol Vis Sci. 2011;52:5441-8 pubmed publisher

Luxenhofer R, Schulz A, Roques C, Li S, Bronich T, Batrakova E, et al. Doubly amphiphilic poly(2-oxazoline)s as high-capacity delivery systems for hydrophobic drugs. Biomaterials. 2010;31:4972-9 pubmed publisher

Ren Y, Zhou X, Mei M, Yuan X, Han L, Wang G, et al. MicroRNA-21 inhibitor sensitizes human glioblastoma cells U251 (PTEN-mutant) and LN229 (PTEN-wild type) to taxol. BMC Cancer. 2010;10:27 pubmed publisher

Cochrane D, Howe E, Spoelstra N, Richer J. Loss of miR-200c: A Marker of Aggressiveness and Chemoresistance in Female Reproductive Cancers. J Oncol. 2010;2010:821717 pubmed publisher

Wang Y, Cheong C, Hall T, Wang Z. Engineering splicing factors with designed specificities. Nat Methods. 2009;6:825-30 pubmed publisher

Mielgo A, Torres V, Clair K, Barbero S, Stupack D. Paclitaxel promotes a caspase 8-mediated apoptosis through death effector domain association with microtubules. Oncogene. 2009;28:3551-62 pubmed publisher

Purev E, Neff L, Horne W, Baron R. c-Cbl and Cbl-b act redundantly to protect osteoclasts from apoptosis and to displace HDAC6 from beta-tubulin, stabilizing microtubules and podosomes. Mol Biol Cell. 2009;20:4021-30 pubmed publisher

Hsiao Y, Tong Z, Westfall J, Ault J, Page McCaw P, Ferland R. Ahi1, whose human ortholog is mutated in Joubert syndrome, is required for Rab8a localization, ciliogenesis and vesicle trafficking. Hum Mol Genet. 2009;18:3926-41 pubmed publisher

Kim K, Xie Y, Tytler E, Woessner R, Mor G, Alvero A. KSP inhibitor ARRY-520 as a substitute for Paclitaxel in Type I ovarian cancer cells. J Transl Med. 2009;7:63 pubmed publisher

Brimacombe K, Hall M, Auld D, Inglese J, Austin C, Gottesman M, et al. A dual-fluorescence high-throughput cell line system for probing multidrug resistance. Assay Drug Dev Technol. 2009;7:233-49 pubmed publisher

Dumont S, Mitchison T. Compression regulates mitotic spindle length by a mechanochemical switch at the poles. Curr Biol. 2009;19:1086-95 pubmed publisher

Fessler S, Wotkowicz M, Mahanta S, Bamdad C. MUC1* is a determinant of trastuzumab (Herceptin) resistance in breast cancer cells. Breast Cancer Res Treat. 2009;118:113-24 pubmed publisher

Kim R, Coates J, Bowles T, McNerney G, Sutcliffe J, Jung J, et al. Arginine deiminase as a novel therapy for prostate cancer induces autophagy and caspase-independent apoptosis. Cancer Res. 2009;69:700-8 pubmed publisher

Prosser S, Straatman K, Fry A. Molecular dissection of the centrosome overduplication pathway in S-phase-arrested cells. Mol Cell Biol. 2009;29:1760-73 pubmed publisher

Suberbielle E, Stella A, Pont F, Monnet C, Mouton E, Lamouroux L, et al. Proteomic analysis reveals selective impediment of neuronal remodeling upon Borna disease virus infection. J Virol. 2008;82:12265-79 pubmed publisher

Karmali P, Kotamraju V, Kastantin M, Black M, Missirlis D, Tirrell M, et al. Targeting of albumin-embedded paclitaxel nanoparticles to tumors. Nanomedicine. 2009;5:73-82 pubmed publisher

Horning J, Sahoo S, Vijayaraghavalu S, Dimitrijevic S, Vasir J, Jain T, et al. 3-D tumor model for in vitro evaluation of anticancer drugs. Mol Pharm. 2008;5:849-62 pubmed publisher

Chen Y, Hsu H, Chen Y, Tsai T, How C, Wang C, et al. Oct-4 expression maintained cancer stem-like properties in lung cancer-derived CD133-positive cells. PLoS ONE. 2008;3:e2637 pubmed publisher

Sanchez A. Analysis of filovirus entry into vero e6 cells, using inhibitors of endocytosis, endosomal acidification, structural integrity, and cathepsin (B and L) activity. J Infect Dis. 2007;196 Suppl 2:S251-8 pubmed

Andersen A, Warren D, Brunsvig P, Aamdal S, Kristensen G, Olsen H. High sensitivity assays for docetaxel and paclitaxel in plasma using solid-phase extraction and high-performance liquid chromatography with UV detection. BMC Clin Pharmacol. 2006;6:2 pubmed